Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
JACC. Cardiovascular Interventions|October 20, 2022
Sex-Related Differences in Thrombus Burden in STEMI Patients Undergoing Primary Percutaneous Coronary InterventionMaria Virginia Manzi, Sergio Buccheri, Sanjit S Jolly, et al.
The Journal of Invasive Cardiology|November 29, 2022
Association Between 3D-Angiography Based Fractional Flow Reserve and Non-Invasive Myocardial Ischemia Testing: The FAST ISCHEMIA StudyAlessandra Scoccia, Tara Neleman, Mariusz Tomaniak, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 10, 2022
Cardiac Catheterizations in Patients With Acute Coronary Syndrome and Prior Coronary Bypass Surgery: Impact of Native vs Graft vs Absent Culprit Lesions on Clinical Outcomes and Treatment StrategyFrederik T W Groenland, Jay Yee, Karim D Mahmoud, et al.
European Heart Journal. Acute Cardiovascular Care|November 14, 2013
Interhospital transfer due to failed prehospital diagnosis for primary percutaneous coronary intervention: an observational study on incidence, predictors, and clinical impactKarim D Mahmoud, Youlan L Gu, Maarten W Nijsten, et al.
Journal of the American College of Cardiology|August 6, 2011
Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysisPieter J Vlaar, Karim D Mahmoud, David R Holmes, et al.
Heart (British Cardiac Society)|March 9, 2012
Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient data pooled analysis of randomised studiesRaffaele Piccolo, Youlan L Gu, Allan Zeeberg Iversen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 25, 2014
Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised controlled trialsRaffaele Piccolo, Ingo Eitel, Allan Zeeberg Iversen, et al.
Vascular Pharmacology|June 15, 2015
Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionRaffaele Piccolo, Ingo Eitel, Gennaro Galasso, et al.
Chronobiology International|April 22, 2014
Time of symptom onset and value of myocardial blush and infarct size on prognosis in patients with ST-elevation myocardial infarctionWouter G Wieringa, Chris P H Lexis, Karim D Mahmoud, et al.
The American Journal of Cardiology|September 7, 2014
Effects of baseline coronary occlusion and diabetes mellitus in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionRaffaele Piccolo, Gennaro Galasso, Allan Zeeberg Iversen, et al.
Pageof 3